Recent 8-K filings for SYRA

• May 07, 2026 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  Syra Health posts first profitable quarter in Q1 2026; net income $241K, EPS $0.02, revenue up 22%

  Net income of $241,000 vs net loss of $(472,265) in Q1 2025; EPS $0.02 vs ($0.04).

• Mar 12, 2026 23:59 UTC earnings materiality 0.80 positive item 2.02item 9.01

  Syra Health FY2025 net loss down 76%; Population Health revenue up 157% to $5.3M

  FY2025 revenue $7.2M (-9% YoY); net loss improved 76% to ($896K) from ($3.8M).

• Dec 18, 2025 23:59 UTC leadership materiality 0.60 neutral item 5.02item 8.01item 9.01

  Syra Health appoints Gregory R. Alexander as CEO effective Jan 5, 2026

  New CEO Gregory R. Alexander receives $251k base salary, 30% target bonus, and 110,537 RSUs.

• Nov 18, 2025 23:59 UTC other_material materiality 0.30 neutral item 5.03item 9.01

  Syra Health amends charter to modify Class B conversion triggers and transfer rules

  Stockholders approved charter amendments on Nov 14, 2025; Certificate of Amendment filed and effective Nov 18, 2025.

• Nov 14, 2025 23:59 UTC other_material materiality 0.35 neutral item 5.07

  Syra Health shareholders approve Class B charter amendments and elect directors

  All five director nominees elected; top vote-getter Priya Prasad 9,093,067 for, 4,508,108 against.

• Nov 12, 2025 23:59 UTC earnings materiality 0.60 negative item 2.02item 9.01

  Syra Health Q3 revenue falls 26% to $1.7M; population health up 96%, net loss down 46%

  Revenue $1.7M, down from $2.3M YoY due to federal spending cuts.

• Aug 15, 2025 23:59 UTC leadership materiality 0.20 neutral item 5.02

  Syra Health appoints Radhika Mereddy to Board of Directors

  Radhika Mereddy appointed to Syra Health's Board on August 13, 2025.

• Aug 12, 2025 23:59 UTC earnings materiality 0.70 positive item 2.02item 9.01

  Syra Health Q2 net loss narrows 95% to $64K; gross margin surges to 38.7%

  Net loss of $64K ($0.01 EPS) vs $1.4M loss ($0.21 EPS) in Q2 2024; adjusted EBITDA improved to ($54K) from ($1.4M).

• Jul 30, 2025 23:59 UTC leadership materiality 0.25 neutral item 5.02

  Director Deepika Vuppalanchi resigns from Syra Health board for personal reasons

  Deepika Vuppalanchi resigned from the Board of Directors on July 28, 2025, for personal reasons.

• Jun 17, 2025 23:59 UTC leadership materiality 0.75 negative item 5.02

  Syra Health terminates CEO Deepika Vuppalanchi for cause; CFO appointed interim CEO

  Board terminated CEO Deepika Vuppalanchi for cause on June 13, 2025.

• May 20, 2025 23:59 UTC leadership materiality 0.65 neutral item 8.01item 9.01

  Syra Health board launches national CEO search; Vuppalanchi interim

  Board initiates a national search for a new CEO to succeed current CEO Dr. Deepika Vuppalanchi.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.60 · Most common event leadership

3 positive 2 negative 6 neutral

source · SYRA on sec.gov